Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
Condition(s) studied
Study summary
This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.
Eligibility
Primary outcome measure(s)
- Major Adverse Cardiovascular Events — 5 years
Composite end points of Cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Division of Cardiology, Peking University First Hospital | Beijing | Beijing Municipality | Recruiting |
More Peking University First Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06489080 on ClinicalTrials.gov ↗ ← All trials in China